You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 1, January 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (86)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Adolescent Medicine
 •Tobacco
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nicotine Patch Therapy in 101 Adolescent Smokers

Efficacy, Withdrawal Symptom Relief, and Carbon Monoxide and Plasma Cotinine Levels

Richard D. Hurt, MD; Gary A. Croghan, PhD, MD; Scott D. Beede, MD; Troy D. Wolter, MS; Ivana T. Croghan, PhD; Christi A. Patten, PhD

Arch Pediatr Adolesc Med. 2000;154:31-37.

Objectives  To determine the efficacy of nicotine patch therapy in adolescents who want to stop smoking and to assess biochemical markers of smoking and nicotine intake.

Design  Nonrandomized, open-label trial using a 15 mg/16 h patch.

Setting  Two midwestern cities.

Subjects  One hundred one adolescents aged 13 through 17 years smoking at least 10 cigarettes per day (cpd).

Intervention  Six weeks of nicotine patch therapy and follow-up visits at 12 weeks and 6 months.

Main Outcome Measures  Self-reported smoking abstinence verified by expired-air carbon monoxide (CO) level of no more than 8 ppm, nicotine withdrawal symptoms, and plasma cotinine level.

Results  Forty-one participants were female (mean [± SD] age, 16.5 [± 1.1] years). Median baseline smoking rate was 20.0 cpd (range, 10-40 cpd). Biochemically confirmed point prevalence smoking abstinence was 10.9% (11/101) at 6 weeks and 5.0% (5/101) at 6 months. The mean (± SD) plasma cotinine level at baseline was 1510.9 ± 732.7 nmol/L; for nonsmoking subjects at weeks 3 and 6, 607.8 ± 386.2 and 710.0 ± 772.5 nmol/L, respectively. Plasma cotinine levels were correlated with CO levels at baseline (r = 0.27; P = .006), week 3 (r = 0.34; P = .004), and week 6 (r = 0.26; P = .03) and with mean cigarettes smoked per day during weeks 3 (r = 0.24; P = .04) and 6 (r = 0.30; P = .02). Mean smoking rates decreased significantly during the study, an effect that lessened at 12 weeks and 6 months.

Conclusions  Nicotine patch therapy plus minimal behavioral intervention does not appear to be effective for treatment of adolescent smokers. Plasma cotinine and CO levels appear to be valid measures of smoking rates during the cessation process, but not at baseline. Smoking rates were reduced throughout the study. Additional pharmacological and behavioral treatments should be considered in adolescent smokers.


From the the Nicotine Dependence Center (Drs Hurt, G. Croghan, I. Croghan, and Patten), Division of Community Internal Medicine (Dr Hurt), Division of General Internal Medicine (Dr G. Croghan), and Section of Biostatistics (Mr Wolter), Mayo Clinic, Rochester, Minn; and the Division of General Internal Medicine, Franciscan Skemp Healthcare, La Crosse, Wis (Dr Beede).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mass Media for Smoking Cessation in Adolescents
Solomon et al.
Health Educ Behav 2009;36:642-659.
ABSTRACT  

A Randomized Trial of Nicotine Nasal Spray in Adolescent Smokers
Rubinstein et al.
Pediatrics 2008;122:e595-e600.
ABSTRACT | FULL TEXT  

Factors associated with recruitment and retention of youth into smoking cessation intervention studies--a review of the literature
Backinger et al.
Health Educ Res 2008;23:359-368.
ABSTRACT | FULL TEXT  

Developing Smoking Cessation Programs for Chronically Ill Teens: Lessons Learned from Research with Healthy Adolescent Smokers
Robinson et al.
J Pediatr Psychol 2008;33:133-144.
ABSTRACT | FULL TEXT  

Pharmacotherapy for adolescent smoking cessation.
Colby and Gwaltney
JAMA 2007;298:2182-2184.
FULL TEXT  

Randomized, Double-blind, Placebo-Controlled Trial of 2 Dosages of Sustained-Release Bupropion for Adolescent Smoking Cessation
Muramoto et al.
Arch Pediatr Adolesc Med 2007;161:1068-1074.
ABSTRACT | FULL TEXT  

Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial.
Roddy et al.
Tobacco Control 2006;15:373-376.
ABSTRACT | FULL TEXT  

Youth Tobacco Use: A Global Perspective for Child Health Care Clinicians
Prokhorov et al.
Pediatrics 2006;118:e890-e903.
ABSTRACT | FULL TEXT  

Comparison of Pharmacological Treatments for Opioid-Dependent Adolescents: A Randomized Controlled Trial
Marsch et al.
Arch Gen Psychiatry 2005;62:1157-1164.
ABSTRACT | FULL TEXT  

Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction
Moolchan et al.
Pediatrics 2005;115:e407-e414.
ABSTRACT | FULL TEXT  

Childhood smoking is an independent risk factor for obstructive airways disease in women
Patel et al.
Thorax 2004;59:682-686.
ABSTRACT | FULL TEXT  

Nicotine Replacement Therapy for Teenagers: About Time or a Waste of Time?
Adelman
Arch Pediatr Adolesc Med 2004;158:205-206.
FULL TEXT  

"Start to stop": results of a randomised controlled trial of a smoking cessation programme for teens
Robinson et al.
Tobacco Control 2003;12:iv26-33.
ABSTRACT | FULL TEXT  

Adolescent and young adult tobacco prevention and cessation: current status and future directions
Backinger et al.
Tobacco Control 2003;12:iv46-53.
ABSTRACT | FULL TEXT  

Characteristics of African American Teenage Smokers Who Request Cessation Treatment: Implications for Addressing Health Disparities
Moolchan et al.
Arch Pediatr Adolesc Med 2003;157:533-538.
ABSTRACT | FULL TEXT  

Teen smoking cessation
Mermelstein
Tobacco Control 2003;12:i25-34.
ABSTRACT | FULL TEXT  

Adolescent Smoking Cessation Services of School-Based Health Centers
Price et al.
Health Educ Behav 2003;30:196-208.
ABSTRACT  

Simultaneous Analysis of Nicotine, Nicotine Metabolites, and Tobacco Alkaloids in Serum or Urine by Tandem Mass Spectrometry, with Clinically Relevant Metabolic Profiles
Moyer et al.
Clin. Chem. 2002;48:1460-1471.
ABSTRACT | FULL TEXT  

Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study
DiFranza et al.
Tobacco Control 2002;11:228-235.
ABSTRACT | FULL TEXT  

Smoking Cessation Counseling: Training and Practice Among Women Pediatricians
Malarcher et al.
CLIN PEDIATR 2002;41:341-349.
ABSTRACT  

Tobacco Use Outcomes of Adolescents Treated Clinically for Nicotine Dependence
Patten et al.
Arch Pediatr Adolesc Med 2001;155:831-837.
ABSTRACT | FULL TEXT  

Smoking Cessation in Adolescents: The Role of Nicotine Dependence, Stress, and Coping Methods
Siqueira et al.
Arch Pediatr Adolesc Med 2001;155:489-495.
ABSTRACT | FULL TEXT  

Promoting Adolescent Smoking Cessation Is Worth the Effort
McFee et al.
Arch Pediatr Adolesc Med 2001;155:419-420.
FULL TEXT  

The Pediatrician's Role in Reducing Tobacco Exposure in Children
Stein et al.
Pediatrics 2000;106:66e-66.
ABSTRACT | FULL TEXT  

A 36-Year-Old Woman Who Smokes Cigarettes
Rigotti
JAMA 2000;284:741-749.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.